Crossmark

Cancer prognosis prediction using somatic point mutation and copy number variation data: a comparison of gene-level and pathway-based models

Published Online: 2020-10-20

Published Print: 2020-12

Authors

Zheng, Xingyu

Amos, Christopher I.

Frost, H. Robert https://orcid.org/0000-0002-6794-9945
Funding

Funding for this research was provided by:

U.S. National Library of Medicine (K01LM012426)

National Cancer Institute (U01CA196386)

National Cancer Institute (P30CA023108)

National Cancer Institute (CA023108)

National Cancer Institute (U19CA203654)

National Institute of General Medical Sciences (P20GM130454)

Cancer Prevention and Research Institute of Texas (RR170048)
License Information

Text and Data Mining valid from 2020-10-20

Version of Record valid from 2020-10-20
More Information

Article History

Received: 15 May 2020

Accepted: 30 September 2020

First Online: 20 October 2020

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current